Picture of Bio Vitos Pharma AB logo

BIOVIT Bio Vitos Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: Hemcheck Sweden AB - Q4 Pretax Loss Sek 3.1 Million

Feb 19 (Reuters) - Hemcheck Sweden AB  HEMC.ST :
    * HEMCHECK SWEDEN AB - Q4 OPERATING REVENUE SEK 0.1 MILLION VERSUS SEK 0 MILLION YEAR AGO
    * HEMCHECK SWEDEN AB - Q4 PRETAX LOSS SEK 3.1 MILLION VERSUS LOSS SEK 1.3 MILLION YEAR AGO

Source text for Eikon:  ID:nWkrCp2vJ 
Further company coverage:  HEMC.ST 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Bio Vitos Pharma AB

See all news